Featured News

A report published in the October 22 edition of the Centers for Disease Control and Prevention’s Morbidity and Mortality Weekly Report (MMWR) describes the first known case of HIV transmission from a blood transfusion since 2002.

The Patient Protection and Affordable Care Act (PPACA), signed into law by President Barack Obama on March 23, 2010, will allow individuals and businesses to purchase health insurance directly through exchanges—competitive marketplaces where buyers can compare coverage. 

NHF is pleased to announce that Perseus Patel of Hercules, California, is the 2010 Kevin Child Scholarship Winner. 

The Get Ingrained Foundation has chosen the National Hemophilia Foundation’s Youth Fit Program (formerly “Team Hemophilia”) as one of its five finalists to win a $15,000 grant. 

Last month, Actavis, an Iceland-based pharmaceutical company specializing in generic drugs, issued a voluntary recall to wholesale and retail level distributors of 18 lots of Fentanyl Transdermal System 25 mcg/hour C-II patches.

A study published in October suggests that oral tranexamic acid (TA) may have two benefits: reducing heavy menstrual bleeding (menorrhagia) in women and improving their quality of life. 

Using genetically modified plants, researchers from two Florida universities are developing a technique that could help prevent treatment-related complications such as inhibitors, an immune reaction that neutralizes infused factor, and anaphylaxis, severe allergic reactions, in people with hemophilia B.

On October 5, 2010, the Improving Access to Clinical Trials Act (P.L. 111-255) was signed into law.